Market Sentiment

World

A New Axis Emerges: Meloni and Merz Forge Conservative Alliance, Diminishing Macron's Role in EU Leadership

Italian Prime Minister Giorgia Meloni and German Chancellor Friedrich Merz have signed a landmark partnership pact in Rome, signaling a potential shift in the European Union's traditional Franco-German power center. The accord, focusing on defense, migration, and trade, comes as France grapples with political instability and a weakened presidency.

Feb 2, 2026

Business

TAKKT AG's Three-Year Slump: Long-Term Shareholders Grapple with 68% Loss

Investors in German B2B specialist TAKKT AG (ETR:TTK) have faced a punishing three years, with total shareholder returns plummeting 68%. As revenue declines and the share price continues to slide, we examine the fundamentals behind the downturn and what it signals for the company's future.

Feb 2, 2026

Business

Russian Crypto Mining Mogul Igor Runets Placed Under House Arrest in Major Tax Evasion Case

Igor Runets, founder and CEO of Russia's largest Bitcoin mining operator BitRiver, has been detained and placed under house arrest on charges of large-scale tax evasion. The case unfolds against a backdrop of Western sanctions and operational challenges for the once-dominant firm.

Feb 2, 2026

Business

Small-Cap Surge: London's Overlooked Stocks Spark Investor Frenzy

As the FTSE 100 hits record highs, a broader rally in UK mid and small-cap indices is prompting a strategic rethink. Analysts debate whether these long-neglected shares, now showing historic undervaluation, are poised for a major comeback.

Feb 2, 2026

Business

From Novice to Millionaire: How a 40-Year Investment Journey Built a £2m ISA Fortune

At 77, Jane Perry's £2 million ISA portfolio stands as a testament to a simple, disciplined investment strategy begun in the 1980s. Her story challenges the gender investment gap and offers a blueprint for long-term wealth building.

Feb 2, 2026

Business

Order Book Battle: How Visible Liquidity Walls Held Bitcoin Back While Metals Soared

As gold and silver surged to record highs last month, Bitcoin's puzzling stagnation below $90,000 had traders searching for answers. A closer look at exchange order books reveals a deliberate play by large players to suppress price—a tactic that ultimately set the stage for last week's sharp decline.

Feb 2, 2026

Business

Emma Bridgewater Sees Path to Profitability as Recovery Plan Gains Traction

The iconic pottery maker reports encouraging sales growth and a renewed focus on its craft heritage, aiming to return to profitability next year after a period of job cuts and industry-wide challenges.

Feb 2, 2026

Business

Zixin Group Holdings Sees Promising ROCE Growth, Signaling Potential for Long-Term Value

The Singapore-listed food company has turned profitable after years of losses, with a 12% return on capital employed and a significant expansion in its capital base—key indicators watched by investors seeking compounding growth stocks.

Feb 2, 2026

Business

Acsion Ltd: A Deep Dive into the JSE-Listed Property Developer's Investment Merits

Amidst the allure of high-growth tech narratives, Acsion (JSE:ACS) presents a case for steady, profitable growth. With strong insider alignment and improving margins, does this property-focused stock warrant a closer look from discerning investors?

Feb 2, 2026

World

Thai Heartland Reckoning: Rural Voters Rethink Loyalties, Threatening Pheu Thai's Populist Dominance

In Thailand's crucial northeast, a profound political realignment is underway. Farmers, disillusioned by unmet promises and economic hardship, are abandoning decades of party loyalty to back individual candidates, testing the foundations of the Shinawatra family's political machine ahead of pivotal elections.

Feb 2, 2026

Business

Kuya Silver's Record Output at Bethania Fuels Expansion Hopes, But Valuation Questions Loom

Kuya Silver reports a record quarterly production haul from its Bethania silver mine alongside accelerated underground development, drawing investor focus. However, a premium valuation against a backdrop of ongoing losses presents a complex picture for the junior miner.

Feb 2, 2026

Business

SBA Communications Stock Slump: A Buying Opportunity or a Sign of Deeper Trouble?

Shares of SBA Communications have faced persistent pressure, declining over 5% in the past year. A detailed analysis of its discounted cash flow and P/E ratio suggests the wireless infrastructure REIT may be significantly undervalued, presenting a potential entry point for long-term investors.

Feb 2, 2026

Business

iRhythm Completes Corporate Overhaul, Establishes New Holding Company Structure

Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.

Feb 2, 2026

Business

Tandem Diabetes Care: A Value Play After Steep Decline, or Value Trap?

Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.

Feb 2, 2026

Business

Travere Therapeutics Under Investigation: Legal Scrutiny Clouds Biotech's Path to Profitability

Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.

Feb 2, 2026

Business

Bitcoin's Slide Below $75K Puts MicroStrategy's Billion-Dollar Bet in the Red

A sharp correction in Bitcoin prices has pushed MicroStrategy's massive holdings into significant paper losses, testing the resolve of the corporate sector's most vocal crypto advocate and raising questions about the sustainability of its accumulation strategy.

Feb 2, 2026

Sanofi's Genetic Disorder Drug Shows Promise in Gaucher Trial, Stumbles in Fabry Study

Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.

Feb 2, 2026

Business

CrossCurve Bridge Exploit Highlights Persistent DeFi Security Woes, $3M Drained

Cross-chain protocol CrossCurve has been exploited for an estimated $3 million, with a critical smart contract flaw allowing unauthorized fund withdrawals across multiple blockchains. The incident renews scrutiny on bridge security and user protections in decentralized finance.

Feb 2, 2026

World

Pakistan Launches Major Counter-Operation in Balochistan After Deadly Coordinated Assaults

Following a series of brazen, coordinated attacks claimed by a separatist group that killed dozens, Pakistani security forces report a sweeping response resulting in over 140 militant casualties, as tensions with neighboring India and Afghanistan flare.

Feb 2, 2026

Business

USA Rare Earth Secures $3.1B in Federal and Private Funding, Fueling Ambitions to Challenge China's Dominance

Backed by a major U.S. government loan and a surge in private equity, USA Rare Earth is accelerating its domestic mining and manufacturing projects, positioning itself at the forefront of a critical national strategy.

Feb 2, 2026